# A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

> **NCT00798395** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 32 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders
- Mental Disorders

## Interventions

- **DRUG:** Org 50081
- **DRUG:** Org 50081
- **DRUG:** Placebo
- **DRUG:** zopiclone

## Key facts

- **NCT ID:** NCT00798395
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798395, "A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00798395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*